Springer Nature
Browse
13395_2019_218_MOESM4_ESM.pdf (1.01 MB)

MOESM4 of Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy

Download (1.01 MB)
journal contribution
posted on 2019-12-13, 07:39 authored by Cynthia Shu, Ariana Kaxon-Rupp, Judd Collado, Robert Damoiseaux, Rachelle Crosbie
Additional file 4: Figure S2. C2C12 myoblasts undergoing differentiation and fusion into myotubes. Confluent C2C12 myoblasts (day 0, D0) were switched from proliferation to differentiation media and imaged daily using phase contrast microscopy for 7 days (D1 to D7). Scale bar = 200 μm.

Funding

National Institute of Arthritis and Musculoskeletal and Skin Diseases

History

Usage metrics

    Skeletal Muscle

    Categories

    Keywords

    Drug discoveryDuchenne muscular dystrophyC2C12DystrophinFelodipineHigh-throughput screenSarcolemmaSarcospanSmall molecules

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC